|
The Cancer Immunology (CIMM) Working Group Town Meeting:
Cancer Immunotherapy: The View From The Private Sector
Co-Chairpersons: Olivera J. Finn, University of Pittsburgh School of Medicine, Pittsburgh, PA; and Elizabeth M. Jaffee, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
- Hyam I. Levitsky, Hoffman-La Roche Inc., Nutley, NJ
- Ira Mellman, Genentech, Inc., South San Francisco, CA
- Jon M. Wigginton, Bristol-Myers Squibb Co., Princeton, NJ
The Chemistry in Cancer Research (CICR) Working Group Town Meeting
Co-Chairpersons: Stephen Neidle, University of London School of Pharmacy, London, United Kingdom; and Billy W. Day, University of Pittsburgh School of Pharmacy, Pittsburgh, PA
The Minorities in Cancer Research (MICR) Town Meeting
Chairperson: Levi A. Garraway, Dana-Farber Cancer Institute, Boston, MA
The Molecular Epidemiology (MEG) Working Group Town Meeting:
Update on Cancer Survivorship
Co-Chairpersons: Kathy J. Helzlsouer, Mercy Medical Center, Baltimore, MD; and James R. Cerhan, Mayo Clinic College of Medicine, Rochester, MN
- Joanne L. Elena, National Cancer Institute, Bethesda, MD
The Tumor Microenvironment (TME) Working Group Town Meeting:
Drug Targets in the Tumor Microenvironment
Co-Chairpersons: Kornelia Polyak, Dana-Farber Cancer Institute, Boston, MA; and M. Celeste Simon, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
- Rebecca G. Bagley. Genzyme Corp., Framingham, MA
- Giovanni Melillo, Bristol-Myers Squibb Co., Princeton, NJ
- Hegde Priti, Genentech, Inc., South San Francisco, CA
|